Malek Faham - Concepedia

Author

Malek Faham

Adaptive Biotechnologies (United States)

Also Known As

Faham Malek, Faham, Malek, Leonard, John P., M Faham, M. Faham, Malek Faham

174

Publications

8.8K

Citations

H-Index

101

Concepts

All Affiliations

Adaptive Biotechnologies (United States)Stanford University University of California, San Francisco Dana-Farber Cancer Institute New York Genome Center

About

Malek Faham is an author at Adaptive Biotechnologies (United States) specializing in medicine, genetics, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	4K
2	Engineering	4	4	1.4K
3	Health Sciences	4	4	566
4	Public Health	4	4	607
5	Natural Sciences	2	2	176

Malek Faham

Publications

8.5K

Citations

H-Index

Page 1

	Year	Citations
Diverse somatic mutation patterns and pathway alterations in human cancers Zhengyan Kan, Bijay S. Jaiswal, Jeremy Stinson, Nature Cancer ResearchEngineeringPathway AlterationsSomatic VariantTumor Heterogeneity	2010	1K
Mutations in the Gene Encoding Cystatin B in Progressive Myoclonus Epilepsy (EPM1) L Pennacchio, Anna‐Elina Lehesjoki, Nancy Stone, Science	1996	539
Population structure, differential bias and genomic control in a large-scale, case-control association study David Clayton, Neil Walker, Deborah J. Smyth, Nature Genetics Genome-wide Association StudyGenetic AnalysisGenotype-phenotype AssociationMedicineGenetics	2005	529
A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation Nila Patil, David R. Cox, Deepti Bhat, Nature Genetics Signal TransductionMolecular PhysiologyHyperpolarization (Biology)Granule Cell DifferentiationMedicine	1995	510
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study Mark Roschewski, Kieron Dunleavy, Stefania Pittaluga, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaOncologyTumour DnaCt Monitoring	2015	449
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma Joaquín Martínez‐López, Juan José Lahuerta, François Pépin, Blood	2014	424
Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia Malek Faham, Jianbiao Zheng, Martin Moorhead, Blood	2012	408
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma Aurore Perrot, Valérie Lauwers‐Cancès, Jill Corre, Blood	2018	408
Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients Edward Cha, Mark Klinger, Yafei Hou, Science Translational Medicine	2014	376
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing David M. Kurtz, Michael R. Green, Scott V. Bratman, Blood	2015	336

Page 1